Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of October, 2022

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒             Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches, the first of which was completed on October 26, 2022. In respect of each of the two tranches, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the second tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on June 15, 2022, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended October 31, 2022, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



   Ordinary Shares
     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

October 3, 2022

     158,526        242.31p        243.50p        236.00p  

October 4, 2022

     167,048        244.19p        247.50p        239.50p  

October 5, 2022

     176,489        244.45p        246.00p        240.00p  

October 6, 2022

     183,376        250.86p        255.50p        246.00p  

October 7, 2022

     203,840        220.45p        240.00p        211.00p  

October 10, 2022

     245,714        224.30p        231.00p        219.50p  

October 11, 2022

     253,269        217.41p        224.50p        211.50p  

October 12, 2022

     264,861        215.92p        219.00p        206.00p  

October 13, 2022

     271,644        216.73p        220.00p        211.50p  

October 14, 2022

     273,465        223.65p        225.50p        219.00p  

October 17, 2022

     82,217        227.88p        229.00p        223.50p  

October 18, 2022

     38        229.00p        229.00p        229.00p  

October 19, 2022

     177,073        232.09p        233.00p        227.00p  

October 20, 2022

     229,136        231.16p        235.00p        226.50p  

October 21, 2022

     234,760        231.42p        235.50p        223.50p  

October 24, 2022

     238,607        233.03p        235.50p        225.00p  

October 25, 2022

     241,303        230.52p        237.50p        224.50p  

October 26, 2022

     127,619        239.63p        242.00p        236.50p  

October 28, 2022

     42,543        223.21p        236.50p        231.00p  

October 31, 2022

     40,433        233.57p        236.50p        231.00p  

During the month ended October 31, 2022, the Company repurchased an aggregate of 3,611,961 Ordinary Shares. As of October 31, 2022, the Company’s issued share capital was 289,080,542 shares, 10,268,306 of which were held in treasury, resulting in total voting rights in the Company of 278,812,236 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

October 3, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4531698.html

October 4, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4533032.html

October 5, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4534777.html

October 6, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4536212.html

October 7, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4537828.html

October 10, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4539273.html

October 11, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4540803.html

October 12, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4542535.html

October 13, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4543998.html

October 14, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4545445.html

October 17, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4547077.html

October 18, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4548503.html

October 19, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4550073.html

October 20, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4551687.html

October 21, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4553065.html

October 24, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4554714.html

October 25, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4556176.html

October 26, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4557921.html

October 28, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4560948.html

October 31, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4563450.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: November 3, 2022     By:  

/s/ Daphne Zohar

      Name:   Daphne Zohar
      Title:   Chief Executive Officer